Authors:
Minami, M
Kume, N
Shimaoka, T
Kataoka, H
Hayashida, K
Akiyama, Y
Nagata, I
Ando, K
Nobuyoshi, M
Hanyuu, M
Komeda, M
Yonehara, S
Kita, T
Citation: M. Minami et al., Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions, ART THROM V, 21(11), 2001, pp. 1796-1800
Authors:
Sekine, M
Nagata, H
Tsuji, S
Hirai, Y
Fujimoto, S
Hatae, M
Kobayashi, I
Fujii, T
Nagata, I
Ushijima, K
Obata, K
Suzuki, M
Yoshinaga, M
Umesaki, N
Satoh, S
Enomoto, T
Motoyama, S
Tanaka, K
Citation: M. Sekine et al., Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: Two common founder mutations of BRCA1 in Japanese population, CLIN CANC R, 7(10), 2001, pp. 3144-3150
Authors:
Sekine, M
Nagata, H
Tsuji, S
Hirai, Y
Fujimoto, S
Hatae, M
Kobayashi, I
Fujii, T
Nagata, I
Ushijima, K
Obata, K
Suzuki, M
Yoshinaga, M
Umesaki, N
Satoh, S
Enomoto, T
Motoyama, S
Tanaka, K
Citation: M. Sekine et al., Localization of a novel susceptibility gene for familial ovarian cancer tochromosome 3p22-p25, HUM MOL GEN, 10(13), 2001, pp. 1421-1429
Authors:
Kishimoto, H
Taniguchi, A
Sakai, M
Fukushima, M
Nagasaka, S
Fukunaga, A
Nagata, I
Nakaishi, S
Tokuyama, K
Nakai, Y
Citation: H. Kishimoto et al., Assessments of insulin sensitivity in nonobese Japanese Type 2 diabetic patients: comparison of quantitative insulin sensitivity check index with minimal model approach, DIABET MED, 18(9), 2001, pp. 772-773
Authors:
Yamamoto, K
Kikuchi, Y
Kudoh, K
Nagata, I
Citation: K. Yamamoto et al., Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines (vol 126, pg 168, 2000), J CANC RES, 127(2), 2001, pp. 142-142
Authors:
Taniguchi, A
Nakai, Y
Sakai, M
Yoshii, S
Hayashi, M
Nishitani, K
Hamanaka, D
Nakaishi, S
Kamamoto, T
Nagata, I
Okumura, T
Kishimoto, H
Fukushima, M
Citation: A. Taniguchi et al., Relationship of regional adiposity to insulin resistance in nonobese Japanese type 2 diabetic patients, DIABET CARE, 24(5), 2001, pp. 966-968
Authors:
Kataoka, H
Miyamoto, S
Nagata, I
Ueba, T
Hashimoto, N
Citation: H. Kataoka et al., Venous congestion is a major cause of neurological deterioration in spinalarteriovenous malformations, NEUROSURGER, 48(6), 2001, pp. 1224-1229
Authors:
Namura, S
Nagata, I
Takami, S
Masayasu, H
Kikuchi, H
Citation: S. Namura et al., Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice, STROKE, 32(8), 2001, pp. 1906-1911
Authors:
Zhang, Z
Nagata, I
Kikuchi, H
Xue, JH
Sakai, N
Sakai, H
Yanamoto, H
Citation: Z. Zhang et al., Broad-spectrum and selective serine protease inhibitors prevent expressionof platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage - Vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB, STROKE, 32(7), 2001, pp. 1665-1672
Authors:
Namura, S
Iihara, K
Takami, S
Nagata, I
Kikuchi, H
Matsushita, K
Moskowitz, MA
Bonventre, JV
Alessandrini, A
Citation: S. Namura et al., Intravenous administration of MEK inhibitor U0126 affords brain protectionagainst forebrain ischemia and focal cerebral ischemia, P NAS US, 98(20), 2001, pp. 11569-11574
Authors:
Taniguchi, A
Fukushima, M
Sakai, M
Tokuyama, K
Nagata, I
Fukunaga, A
Kishimoto, H
Doi, K
Yamashita, Y
Matsuura, T
Kitatani, N
Okumura, T
Nagasaka, S
Nakaishi, S
Nakai, Y
Citation: A. Taniguchi et al., Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients, METABOLISM, 50(4), 2001, pp. 477-480
Authors:
Yuan, ZR
Okaniwa, M
Nagata, I
Tazawa, Y
Ito, M
Kawarazaki, H
Inomata, Y
Okano, S
Yoshida, T
Kobayashi, N
Kohsaka, T
Citation: Zr. Yuan et al., The DSL domain in mutant JAG1 ligand is essential for the severity of the liver defect in Alagille syndrome, CLIN GENET, 59(5), 2001, pp. 330-337
Authors:
Tsukamoto, Y
Matsuo, N
Ozawa, K
Hori, O
Higashi, T
Nishizaki, J
Tohnai, N
Nagata, I
Kawano, K
Yutani, C
Hirota, S
Kitamura, Y
Stern, DM
Ogawa, S
Citation: Y. Tsukamoto et al., Expression of a novel RNA-splicing factor, RA301/Tra2 beta, in vascular lesions and its role in smooth muscle cell proliferation, AM J PATH, 158(5), 2001, pp. 1685-1694
Authors:
Fuke, Y
Nagata, I
Maruta, R
Masunaga, T
Kato, T
Ueda, H
Citation: Y. Fuke et al., Effects of vegetables grown with different fertilizers on the yield and biological activities, J JPN SOC F, 47(9), 2000, pp. 700-707
Authors:
Yukawa, H
Takahashi, JC
Miyatake, SI
Saiki, M
Matsuoka, N
Akimoto, M
Yanamoto, H
Nagata, I
Kikuchi, H
Hashimoto, N
Citation: H. Yukawa et al., Adenoviral gene transfer of basic fibroblast growth factor promotes angiogenesis in rat brain, GENE THER, 7(11), 2000, pp. 942-949
Authors:
Hiramatsu, HP
Kikuchi, Y
Seto, H
Nagata, I
Citation: Hp. Hiramatsu et al., In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs, ANTI-CANC D, 11(7), 2000, pp. 573-578
Authors:
Kashima, K
Oite, T
Aoki, Y
Takakuwa, K
Aida, H
Nagata, H
Sekine, M
Wu, HJ
Hirai, Y
Wada, Y
Yamamoto, K
Hasegawa, K
Sonoda, T
Maruo, T
Nagata, I
Ohno, M
Suzuki, M
Kobayashi, I
Kuzuya, K
Takahashi, T
Torii, Y
Tanaka, K
Citation: K. Kashima et al., Screening of BRCA1 mutation using immunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers, JPN J CANC, 91(4), 2000, pp. 399-409
Citation: I. Nagata et al., Isothermal vapor-liquid equilibria of mixtures of (methanol plus ethanol plus l-propanol or 2-propanol) at 333.15 K, FLU PH EQUI, 170(1), 2000, pp. 37-48
Authors:
Yamamoto, K
Kikuchi, Y
Kudoh, K
Hirata, J
Kita, T
Nagata, I
Citation: K. Yamamoto et al., Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma, JPN J CLIN, 30(10), 2000, pp. 446-449